CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
https://doi.org/10.20996/1819-6446-2009-5-3-8-13
Abstract
Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus (DM 2) in current clinical practice.
Material and methods. A total of 200 patients with DM 2, who consented to take part in the questionnaire, were examined. Questionnaire, clinical and laboratory examinations were conducted.
Results. There was a low frequency of CVD recognized and included into clinical diagnosis – angina, history of myocardial infarction and stroke. In majority of the patients decompensated carbohydrate metabolism was observed. This was due to lack of knowledge, inadequate or absent glucose self-monitoring, low frequency of combined glucoselowering therapy. Target level of blood pressure (BP) was registered in 16% of hypertensive patients only. Basic reasons of this were: frequently prescribed mono-therapy, irrational combinations, inadequate dosage and frequent omissions of antihypertensive drugs intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted cholesterol levels were also revealed in examined patients.
Conclusion. Improvement of diagnostic tactics in patients with DM 2 is necessary as well as therapy correction taking into account these patients co-morbidity.
About the Authors
I. E. Sapozhnikova
Kirov State Medical Academy
Russian Federation
Russian Federation
Chair of Hospital Therapy,
ul. K. Marxa 112, Kirov, 610027E. I. Tarlovskaya
Kirov State Medical Academy
Russian Federation
Russian Federation
Chair of Hospital Therapy,
ul. K. Marxa 112, Kirov, 610027E. N. Anufrieva
Kirov State Medical Academy
Russian Federation
Russian Federation
Chair of Hospital Therapy,
ul. K. Marxa 112, Kirov, 610027References
1. Dedov I.I., Shestakova M.V. Diabetes mellitus. Guidelines for physicians. M.: Universum Publishing; 2003 (in Russian) [Дедов И.И., Шестакова М.В. Сахарный диабет. Руководство для врачей. М.: Универсум Паблишинг; 2003].
2. Alan C., Alan M., Kahn R.C. Joslin’s Diabetes Mellitus. Philadelphia: Lippincott Williams & Wilkins; 2004. P. 976-977.
3. Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.
4. Rydén L, Standl E, Bartnik M et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28(1):88-136.
5. Suntsov U.I., Dedov I.I., Shestakova M.V. Screening of diabetes mellitus complications as the method of quality medical care estimation. М. 2008. (In Russian) [Сунцов Ю.И., Дедов И.И., Шестакова М.В. Скрининг осложнений сахарного диабета как метод оценки качества лечебной помощи больным. М. 2008].
6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317(7160):703-13.
Review
For citations:
Sapozhnikova I.E., Tarlovskaya E.I., Anufrieva E.N. CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 2009;5(3):8-13. https://doi.org/10.20996/1819-6446-2009-5-3-8-13
Views:
659
.jpg)
Email this article 